QR-koodi

MKRN1 degrades AGC1 to trigger chemotherapy resistance of colorectal Cancer

Abstract Oxaliplatin (Oxa) has been extensively employed in treatment of colorectal cancer (CRC), yet frequent occurrence of chemoresistance poses a significant obstacle to achieving long-term disease-free survival for CRC patients. In this study, we employed a CRISPR/Cas9 sgRNA library targeting 1,...

Täydet tiedot

Tallennettuna:
Päätekijät: Yixuan Wang, Mu Qiao, Jing Guo, Ying Xie, Meilin Hu, Xin Li, Sheng Wang, Jingjing Wang, Jingya Wang, Ziyi Peng, Mengqi Wang, Hao Cheng, Tiantian Li, Linchuang Jia, Danchen Su, Huanhuan Liu, Kexin Hu, Xinyang Li, Wenjing Li, Di Wu, Zhe Zhang, Jianing Han, Ruiyang Bai, Funan Zhou, Zhiqiang Liu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2025-07-01
Sarja:Molecular Medicine
Aiheet:
Colorectal cancer
Ubiquitination
MKRN1
AGC1
Heat shock proteins
Mitochondrial energy metabolism
Linkit:https://doi.org/10.1186/s10020-025-01287-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia